Group

Hemophilia is a rare genetic disorder that prevents blood from clotting normally. For people with hemophilia, a small cut or a minor injury can lead to excessive bleeding. Blood coagulation testing is a crucial tool for diagnosing and managing this condition. A coagulation test can identify which coagulation factor is deficient, and the results can be used to monitor the effectiveness of a patient's treatment. The ability of these tests to provide a precise and accurate diagnosis is a major reason for their value. The crucial role of these tests in managing hemophilia is a key factor driving the growth of a significant segment of the Blood Coagulation Testing Market.